• FirefoxInstall the new Firefox »
  •  Dow Down 1.11% Nasdaq Down 0.94%

    AbbVie Inc. (ABBV)

    -NYSE
    58.54 Up 0.30(0.52%) Mar 31, 4:00PM EDT
    |After Hours : 58.30 Down 0.24 (0.41%) Mar 31, 6:07PM EDT
    Add to Portfolio
    Prev Close:58.24
    Open:58.01
    Bid:58.30 x 1000
    Ask:59.94 x 100
    1y Target Est:69.08
    Beta:1.66
    Earnings Date:Apr 23 - Apr 27 (Est.)
    Day's Range:57.71 - 58.81
    52wk Range:45.50 - 70.76
    Volume:12,313,641
    Avg Vol (3m):11,795,800
    Market Cap:93.31B
    P/E (ttm):53.22
    EPS (ttm):1.10
    Div & Yield:2.04 (3.50%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ABBV

    Comparison

    Symbol% ChgMkt Cap
    ABBVUp 0.52%93.31B
    MRKDown 1.47%163.14B
    NVSDown 2.67%236.53B
    PFEDown 0.60%213.22B

    Key Statistics

    Forward P/E (1 yr):11.80
    P/S (ttm):4.65
    Ex-Dividend Date:13-Apr-15

    Analysts

    Annual EPS Est (Dec-15) :4.33
    Quarterly EPS Est (Mar-15) :0.85
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):0.86

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback